Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

PURPOSE: The potential of members of the epidermal growth factor receptor (ErbB) family as drug targets in cholangiocarcinoma (CCA) has not been extensively addressed. Although phase III clinical trials showed no survival benefits of erlotinib in patients with advanced CCA, the outcome of the standa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Boonsri, Boonyakorn, Yacqub-Usman, Kiren, Thintharua, Pakpoom, Myint, Kyaw Zwar, Sae-Lao, Thannicha, Collier, Pam, Suriyonplengsaeng, Chinnawut, Larbcharoensub, Noppadol, Balasubramanian, Brinda, Venkatraman, Simran, Egbuniwe, Isioma U., Gomez, Dhanwant, Mukherjee, Abhik, Kumkate, Supeecha, Janvilisri, Tavan, Zaitoun, Abed M, Kuakpaetoon, Thiti, Tohtong, Rutaiwan, Grabowska, Anna M, Bates, David O., Wongprasert, Kanokpan
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053863/
https://ncbi.nlm.nih.gov/pubmed/33070556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2020.585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados